Be Efficient By Nature
Cyntegrity (origin: clinical + integrity), an innovative company inspired by efficiency, provides a specialized software tool for the risk-based monitoring (RBM).
Our mission is to help a pharmaceutical company to stay GCP compliant, improve patient safety, make a clinical study more predictable, and optimise monitoring resources. In other words: prevent surprises.
We offer trial management tools that are more predictive than retrospective. They integrate the knowledge from previous trials with contextual, real-world data.
Risk-based Monitoring Tool
Our RBM.Cloud builds up a “nervous system” of a clinical trial. It guarantees early risk identification by providing a centralized location where risk data are saved, managed, monitored, and reported.
@RACT
Risk Assessment and Categorization Tool@RACT
@RACT® – the first free cloud version of Risk Assessment and Categorization Tool, originally developed by TransCelerate Group and improved further by Cyntegrity in cooperation with PPH plus. Register today for free!
What is RBM
Risk-based MonitoringWhat is RBM
Risk-based Monitoring (RBM) is becoming an essential concept in pharmaceutical clinical research today.Which has potential to reduce clinical costs and improve data quality, and time-to-market of a medicine.
RBM.cloud
Detect, Manage, MitigateRBM.cloud
Detect, Manage, MitigateTogether with the application EarlyBird® Cyntegrity conducts total risk management of a clinical trial. It analyses data driven KRIs, builds reports and Risk-based Monitoring dashboard.
Recent Posts
Key Risk Indicators Reveal Blind Spots in Clinical Trials
By design, the traditional spot-checking type of audits leave a blind spot on systemic quality threats. Key Risk Indicators however, form the core of a widely applicable concept that captures all relevant risks in scope and provides project managers and QM experts targeted and objective updates on actionable issues and trends.
Interview: “Oncology Trials are Different”
Many risks in clinical trials seem therapy specific. To illustrate this, Dr Johann Proeve shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.
“OncoRACT” – The First Therapy Specific RACT for Clinical Trials
Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.
Latest News
Interview: “Oncology Trials are Different”
Many risks in clinical trials seem therapy specific. To illustrate this, Dr Johann Proeve shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.
“OncoRACT” – The First Therapy Specific RACT for Clinical Trials
Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.
Risk Based Budgeting: 5-Steps to Stay On-Budget
Yes you can stay on-budget! Read how Risk Based Budgeting (RBB) can help you keeping your clinical trial on-budget.
Cyntegrity’s RBM Platform “EarlyBird” offers a variety of useful components to support Risk Based Monitoring. I’m looking forward to the first Implementation in one of our next studies.
Cyntegrity’s @RACT is not just a cloud-based version of RACT. It is a comprehensive system that follows a solid risk management process. @RACT reinforces that process with in-depth analysis tools to support real-time decision making at both the study and enterprise levels.
Great that Cyntegrity offers a tool that operationlizes the TransCelerate RACT tool; even better that this enables through a common platform the sharing of risk assessments what will be key to quality risk management as we should learn from IATA!
I think you developed already a great tool, at least from the look and feel point of view. I have no idea how cumbersome the implementation is, how much programming is required etc. I can also imagine that coming to an agreement on what is a risk and the definition for it probably takes most of the time.
